Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 4 contracts
Sources: Common Stock Warrant Agreement (Cytokinetics Inc), Warrant Agreement (Cytokinetics Inc), Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsImmunoCellular Therapeutics, IncorporatedLtd., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Warrant Agreement (ImmunoCellular Therapeutics, Ltd.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsImmunoCellular Therapeutics, IncorporatedLtd., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Preferred Stock Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Warrant Agreement (ImmunoCellular Therapeutics, Ltd.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsImmunovant, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Immunovant, Inc.), Common Stock Warrant Agreement (Immunovant, Inc.), Warrant Agreement (Immunovant, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsImmunovant, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Immunovant, Inc.), Common Stock Warrant Agreement (Immunovant, Inc.), Warrant Agreement (Immunovant, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCara Therapeutics, Incorporated, Inc. 4 ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇, ▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Cara Therapeutics, Inc.), Warrant Agreement (Cara Therapeutics, Inc.), Warrant Agreement (Cara Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsZIOPHARM Oncology, IncorporatedInc., One First Avenue, ▇▇▇▇▇▇ Building ▇▇, ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Ziopharm Oncology Inc), Preferred Stock Warrant Agreement (Ziopharm Oncology Inc), Warrant Agreement (Ziopharm Oncology Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCymaBay Therapeutics, Incorporated, ▇▇▇ Inc. ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Preferred Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Warrant Agreement (CymaBay Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsProtagonist Therapeutics, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Protagonist Therapeutics, Inc), Common Stock Warrant Agreement (Protagonist Therapeutics, Inc), Debt Securities Warrant Agreement (Protagonist Therapeutics, Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsAllogene Therapeutics, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Allogene Therapeutics, Inc.), Preferred Stock Warrant Agreement (Allogene Therapeutics, Inc.), Warrant Agreement (Allogene Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCymaBay Therapeutics, Incorporated, ▇▇▇ Inc. ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Common Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Warrant Agreement (CymaBay Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, Structure Therapeutics Inc. 6▇▇ ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ., ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇, ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Shares Warrant Agreement (Structure Therapeutics Inc.), Ordinary Shares Warrant Agreement (Structure Therapeutics Inc.), Debt Securities Warrant Agreement (Structure Therapeutics Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Cytokinetics Inc), Preferred Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Cytokinetics Inc), Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Cytokinetics Inc), Common Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCymaBay Therapeutics, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Warrant Agreement (CymaBay Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●¨], Attention: [●¨] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●¨] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Cytokinetics Inc), Preferred Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Cytokinetics Inc), Preferred Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Warrant Agreement (Cytokinetics Inc), Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, Incorporated ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Cytokinetics Inc), Preferred Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Cytokinetics Inc), Common Stock Warrant Agreement (Cytokinetics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCymaBay Therapeutics, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (CymaBay Therapeutics, Inc.), Preferred Stock Warrant Agreement (CymaBay Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsImmunome, IncorporatedInc., ▇▇▇ ▇▇6▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to CytokineticsCymaBay Therapeutics, IncorporatedInc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Preferred Stock Warrant Agreement (CymaBay Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], , Attention: [●] , and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Cytokinetics, Incorporated, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Warrant Agreement (Cytokinetics Inc)